产品介绍 评论(0)
宿主来源
Mouse抗原名称
CD55分子别名
Complement decay-accelerating factor; CR; DAF细胞定位
Secreted, Cell membraneAccession
P08174克隆号
S-3120抗体类型
Mouse mAb抗体同种型
IgG2a,k同型对照
S0B5432反应种属 ?
Hu阳性样本
human peripheral blood leukocytes纯化方式
Protein A浓度
0.2 mg/ml标记
Biotin性状
Liquid缓冲体系
PBS pH7.4, 0.09% sodium azide
储存条件
12 months from date of receipt / reconstitution, 2 to 8 °C as supplied
应用
FCM
稀释度
应用 稀释度 推荐种属 FCM 5μl per million cells in 100μl volume Hu
Decay-accelerating factor (DAF, also known as CD55) is a complement regulatory protein that plays a crucial role in protecting cells from complement-mediated attack. It is a membrane lipid microdomain-associated, GPI-anchored protein that accelerates the decay of C3 and C5 convertases, which are essential for the downstream formation of the membrane attack complex (MAC) in the complement cascade. This action helps prevent excessive complement activation and subsequent cell damage. CD55 is involved in various physiological and pathological processes, including immune regulation, cancer progression, and tissue protection. In cancer, CD55 can promote malignant transformation, cell survival, angiogenesis, and inhibit apoptosis through intracellular signaling pathways such as JNK, JAK/STAT, MAPK/NF-κB, and LCK. Additionally, it is enriched in the cancer stem cell niche and can be induced by chemotherapeutics and hypoxic environments.
流式分析
Flow cytometric analysis of Human CD55 expression on human peripheral blood leukocytes. human peripheral blood leukocytes were stained with either Biotin Mouse IgG2a, κ Isotype Control (left panel) or Biotin Mouse Anti-Human CD55 Antibody (right panel) at 5 μl/test followed by Sav-APC. Flow cytometry and data analysis were performed using Agilent NovoCyte Quanteon and FlowJo™ software.







评论(0)